Terms: = Colorectal cancer AND AFP, AFPD, FETA, HPAFP AND Prognosis
39 results:
1. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
2. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
[TBL] [Abstract] [Full Text] [Related]
3. Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
Li M; Mei YX; Wen JH; Jiao YR; Pan QR; Kong XX; Li J
Cancer Lett; 2023 Apr; 559():216104. PubMed ID: 36863507
[TBL] [Abstract] [Full Text] [Related]
4. Alpha-fetoprotein-producing advanced colorectal cancer: a rare case report and literature review.
Ding H; Xu S; Wang K; Wang X; Sun G; Li X; Ran Y; Sun J
J Int Med Res; 2022 Aug; 50(8):3000605221117218. PubMed ID: 35999811
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and safety of PD-1 inhibitor combined with antiangiogenic therapy for unresectable hepatocellular carcinoma: A multicenter retrospective study.
Yao J; Zhu X; Wu Z; Wei Q; Cai Y; Zheng Y; Hu X; Hu H; Zhang X; Pan H; Zhong X; Han W
Cancer Med; 2022 Oct; 11(19):3612-3622. PubMed ID: 35403359
[TBL] [Abstract] [Full Text] [Related]
6. Influence of afp on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma.
Tan XP; Zhou K; Zeng QL; Yuan YF; Chen W
Clin Exp Med; 2023 Feb; 23(1):107-115. PubMed ID: 35293607
[TBL] [Abstract] [Full Text] [Related]
7. The Impact of a History of Different Other cancers on the Long-Term Outcomes of Patients with Intrahepatic Cholangiocarcinoma: A Population-Based Analysis.
Chai J; Kong J; Zhu K
Biomed Res Int; 2022; 2022():3970884. PubMed ID: 35257009
[TBL] [Abstract] [Full Text] [Related]
8. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients.
Chen Y; Zhang J; Liu J; Wang J; Shi C; Lu L; Cheng X; Niu G; Zhang S
J Immunol Res; 2022; 2022():1817694. PubMed ID: 35224110
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma.
Saad ZM; Fouad Y; Ali LH; Hassanin TM
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
[TBL] [Abstract] [Full Text] [Related]
10. A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27.
Wu D; Wang Y; Yang G; Zhang S; Liu Y; Zhou S; Guo H; Liang S; Cui Y; Zhang B; Ma K; Zhang C; Liu Y; Sun L; Wang J; Liu L
Oncogene; 2020 Sep; 39(38):6099-6112. PubMed ID: 32811980
[TBL] [Abstract] [Full Text] [Related]
11. Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation.
Yamashiro Y; Saito T; Hayashi T; Murakami T; Yanai Y; Tsuyama S; Suehara Y; Takamochi K; Yao T
Histopathology; 2020 Sep; 77(3):492-502. PubMed ID: 32438490
[TBL] [Abstract] [Full Text] [Related]
12. colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases.
Murakami T; Yao T; Yatagai N; Yamashiro Y; Saito T; Sakamoto N; Nagahara A
Histopathology; 2020 Jan; 76(2):325-332. PubMed ID: 31429980
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic Features and Prognostic Factors in Alpha-Fetoprotein-Producing colorectal cancer: Analysis of 78 Cases.
Feng Y; Li Y; Dai W; Mo S; Li Q; Cai S
Cell Physiol Biochem; 2018; 51(5):2052-2064. PubMed ID: 30522102
[TBL] [Abstract] [Full Text] [Related]
14. Α-fetoprotein producing hepatoid gastric adenocarcinoma with neuroendocrine differentiation: A case report.
Li T; Liu T; Wang M; Zhang M
Medicine (Baltimore); 2018 Sep; 97(37):e12359. PubMed ID: 30212993
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis.
Wang Q; Wang G; Liu C; He X
Int J Surg; 2018 Jun; 54(Pt A):92-99. PubMed ID: 29698791
[TBL] [Abstract] [Full Text] [Related]
16. [Standardized diagnosis and treatment of colorectal liver metastasis].
Yao H; Zhang Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):753-757. PubMed ID: 28722087
[TBL] [Abstract] [Full Text] [Related]
17. Human Blood Autoantibodies in the Detection of colorectal cancer.
Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
[TBL] [Abstract] [Full Text] [Related]
18. Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up.
Xu W; Liao W; Ge P; Ren J; Xu H; Yang H; Sang X; Lu X; Mao Y
Medicine (Baltimore); 2016 Apr; 95(17):e3491. PubMed ID: 27124050
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic Value of Carcinoembryonic Antigen (CEA), afp, CA19-9 and CA125 for Patients with colorectal cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
Huo YR; Huang Y; Liauw W; Zhao J; Morris DL
Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996
[TBL] [Abstract] [Full Text] [Related]
20. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
[TBL] [Abstract] [Full Text] [Related]
[Next]